SCOTT SCHLACKMAN
CIK 1645617 · last filed 2026-05-28
SCOTT SCHLACKMAN is a corporate insider who has filed 26 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for MED, was dated May 28, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $502.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$502.1K
1
26
-$1.56M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MED | Director | 42,228 | $11.89 | $502.1K | -$1.56M | 26 | 2026-05-28 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | MED | Grant (A) | +11,680 | $0 | EDGAR |
| 2026-05-12 | MED | Buy (P) | +5,000 | $63.0K | EDGAR |
| 2025-06-26 | MED | Grant (A) | +11,168 | $0 | EDGAR |
| 2024-06-24 | MED | Grant (A) | +6,596 | $0 | EDGAR |
| 2024-03-12 | MED | Mixed | −2,753 | -$123.9K | EDGAR |
| 2023-11-09 | MED | Buy (P) | +52 | $3.6K | EDGAR |
| 2023-08-10 | MED | Buy (P) | +39 | $3.6K | EDGAR |
| 2023-06-20 | MED | Grant (A) | +3,152 | $0 | EDGAR |
| 2023-05-11 | MED | Buy (P) | +13 | $1.2K | EDGAR |
| 2023-03-14 | MED | Mixed | — | -$178.2K | EDGAR |